Nasdaq stss.

Sharps Technology, Inc. (Nasdaq: STSS) is a medical device company that designs and manufactures smart safety syringes. Sharps Technology’s products are designed to eliminate infectious ...Sharp Technology (NASDAQ:STSS) soared 13% on Tuesday as the medical device company announced a deal to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility.Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ...

NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...Find the latest SEC Filings data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.

US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features.

July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best ...Great news for Sharps Technology, Inc. (NASDAQ:STSS): Insiders acquired stock in large numbers last year. Get the latest Sharps Technology, Inc. (STSS) stock news and headlines to help you in your ... Sharps Technology (STSS) Insider Trading Activity 2023. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. [Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off ...Manage market risk and maintain regulatory compliance with Nasdaq Trade Surveillance and Market Abuse Detection Software. Learn more today.Apr 19, 2022 · The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into a definitive agreement with institutional investors for …

Sharps Technology, Inc. (NASDAQ: STSS) The company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. STSS has …

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features.STSS Sharps Technology Inc Statement of Changes in Beneficial Ownership (4) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.Jul 14, 2022 · NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ... NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a …STSS Sharps Technology Inc Form 4 - Statement of changes in beneficial ownership of securities SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Ac...Webull offers Sharps Tech (STSS) historical stock prices, in-depth market analysis, NASDAQ: STSS real-time stock quote data, in-depth charts.Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ...NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

Sharps Technology Inc. Common Stock (STSS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

Sharps Technology, Inc. (NASDAQ:STSS Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 171,000 shares, a decline of 47.6% from the May 31st total of 326,600 shares. Based on an average daily volume of 937,100 shares, the ...STSSNASDAQ STSSNASDAQ 0.4428USD −0.0072 −1.60% Last update at Nov 22, 13:00 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast STSS …WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an ...NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...When is Sharps Technology (NASDAQ:STSS) reporting earnings? Sharps Technology ( STSS) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on May 15 ...

NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...

Sharps Technology, Inc. (Nasdaq: STSS) is a medical device company that designs and manufactures smart safety syringes. Sharps Technology’s products are designed to eliminate infectious ...

WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an ...Sharps Technology Inc. Common Stock (STSS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. STSS Sharps Technology Inc Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400Nov 24, 2023 · STSS Sharps Technology Inc Current Report Filing (8-k) 0001737995 false 0001737995 2023-02-01 2023-02-01 0001737995 STS... NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented, best-in ...InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medical device company Sharps Technology (NASDAQ:STSS) is enjoying a massive su...acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules...Jan 31, 2023 · Dave Gentry. RedChip Companies Inc. 1-800-RED-CHIP (733-2447) Or 407-491-4498. [email protected]. First product shipped from Sharps' facility in Hungary and first to support the Nephron ... Find the latest Financials data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. 10-Year Purchase Agreement: As a result of the proposed acquisition of InjectEZ, Nephron has agreed to a 10-year Purchase Agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 ...

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, and Nephron Pharmaceuticals Corporation, (“Nephron”) a privately owned U.S. leader in contract manufacturing and 503B outsourcing, announce the signing of an Asset Purchase Agreement (APA) to ...Sharps Technology, Inc. (NASDAQ:STSS Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 171,000 shares, a decline of 47.6% from the May 31st total of 326,600 shares. Based on an average daily volume of 937,100 shares, the ... Shares of Sharps Technology, Inc. (NASDAQ:STSS) were down 35% to $0.5301 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules. ...Instagram:https://instagram. dental plans north carolinaregional management corporationpalo alto dig securityjeff bezos real estate investment company 10-Year Purchase Agreement: As a result of the proposed acquisition of InjectEZ, Nephron has agreed to a 10-year Purchase Agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 ... stock kvyoget covered nj reviews Find the latest SEC Filings data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. brokers that allow short selling https://sharpstechnology.com. Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...